GLP-1: An Overview Glucagon-like peptide-1 (GLP-1) agonists act by stimulating insulin secretion in hyperglycemic states, suppressing glucagon secretion in hyperglycemic or euglycemic states, delaying gastric emptying, decreasing appetite, and reducing body weight
Search for a doctor or hospital in your network
Unlike traditional GLP-1 receptor agonists, tirzepatide simultaneously activates both GLP-1 and GIP receptors
Current evidence for GHK-Cu in hair loss is limited to in vitro and animal studies
This helps reduce calorie intake and supports sustainable weight loss
Furthermore, there is no gold standard target for ferroptosis in basic research, which has resulted in many difficulties in transforming basic experiments into clinical and evidence-based medicine